A drug that can be given at the time of a kidney transplant operation will not only cut down the risk of rejection by half but also sets up the foundation for a less toxic regimen of anti-rejection drugs to be used, a new study conducted by Oxford University researchers reveals. The key results are reported in iThe Lancet/i and presented at the World Transplant Congress in San Francisco today. They will help doctors faced with a difficult transplant conundrum: ...
Read More
You have just read an article categorized health
titled Drug can Reduce Risk of Rejection in Kidney Transplantation by Half: Study.
Written by:
editor -
Monday, July 28, 2014
There are currently no comments for "Drug can Reduce Risk of Rejection in Kidney Transplantation by Half: Study"
Post a Comment